<a href="https://laohu8.com/S/MTLS">Materialise NV</a> Reports Q3 Revenue of 66.3 Million EUR, Down 3.5% Year-on-Year
Materialise NV reported consolidated revenue of EUR 66.259 million for the third quarter of 2025, up 2.2% from the previous quarter but down 3.5% compared to the same period in 2024. Revenue from the Materialise Medical segment increased by 10.3% year-over-year, reaching a quarterly record. The Materialise Software segment reported revenue of EUR 10.286 million, down 7.4% from the third quarter of 2024, while the Materialise Manufacturing segment's revenue decreased 17.1% to EUR 22.677 million. Gross profit for the quarter was EUR 37.651 million, compared to EUR 39.297 million in the third quarter of 2024, with a gross margin of 56.8%. Adjusted EBIT stood at EUR 2.918 million, representing 4.4% of consolidated revenue. Overall operational expenses, including R&D, sales and marketing, and general and administrative costs, totaled EUR 36.019 million, a 0.5% increase from the prior-year period. The net cash position increased by EUR 6.724 million to EUR 67.744 million compared to December 31, 2024.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Materialise NV published the original content used to generate this news brief via Business Wire (Ref. ID: 20251028410613) on October 28, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.